Review: taking Adderall xr 30 and Gabapentin together


Summary

Drug interactions are reported among people who take Adderall xr 30 and Gabapentin together. This review analyzes the effectiveness and drug interactions between Adderall xr 30 and Gabapentin. It is created by eHealthMe based on reports of 717 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Adderall xr 30 and Gabapentin >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Adderall Xr 30

Adderall xr 30 has active ingredients of amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. It is often used in attention deficit hyperactivity disorder. (latest outcomes from Adderall xr 30 1,131 users)

Gabapentin

Gabapentin has active ingredients of gabapentin. It is often used in pain. (latest outcomes from Gabapentin 38,775 users)

On Jul, 20, 2016

717 people who take Adderall Xr 30, Gabapentin are studied.


Number of reports submitted per year:

Adderall xr 30 and Gabapentin drug interactions.

Drug effectiveness over time:

Adderall Xr 30:
  • < 1 month: 41.0% - (7 of 17 people)
  • 1 - 6 months: 50.0% - (21 of 42 people)
  • 6 - 12 months: 44.0% - (12 of 27 people)
  • 1 - 2 years: 48.0% - (17 of 35 people)
  • 2 - 5 years: 61.0% - (21 of 34 people)
  • 5 - 10 years: 62.0% - (23 of 37 people)
  • 10+ years: 76.0% - (10 of 13 people)
  • not specified: 0.0% - (0 of 1 people)
Gabapentin:
  • < 1 month: 30.0% - (9 of 30 people)
  • 1 - 6 months: 17.0% - (5 of 29 people)
  • 6 - 12 months: 20.0% - (7 of 34 people)
  • 1 - 2 years: 31.0% - (10 of 32 people)
  • 2 - 5 years: 42.0% - (15 of 35 people)
  • 5 - 10 years: 35.0% - (7 of 20 people)
  • 10+ years: 45.0% - (5 of 11 people)
  • not specified: 50.0% - (2 of 4 people)

Drug effectiveness by gender:

Adderall Xr 30:
  • female: 53.0% - (84 of 157 people)
  • male: 55.0% - (27 of 49 people)
Gabapentin:
  • female: 31.0% - (46 of 148 people)
  • male: 29.0% - (14 of 47 people)

Drug effectiveness by age:

Adderall Xr 30:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 33.0% - (3 of 9 people)
  • 20-29: 69.0% - (25 of 36 people)
  • 30-39: 42.0% - (24 of 56 people)
  • 40-49: 47.0% - (22 of 46 people)
  • 50-59: 64.0% - (33 of 51 people)
  • 60+: 50.0% - (4 of 8 people)
Gabapentin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 33.0% - (3 of 9 people)
  • 20-29: 27.0% - (9 of 33 people)
  • 30-39: 38.0% - (19 of 50 people)
  • 40-49: 33.0% - (15 of 45 people)
  • 50-59: 21.0% - (11 of 51 people)
  • 60+: 42.0% - (3 of 7 people)

Most common drug interactions over time *:

< 1 month:
  • dizziness
  • headache
  • adverse event
  • amnesia
  • coordination abnormal
  • disorientation
  • dyskinesia
  • fatigue
  • feeling abnormal
  • mood swings
1 - 6 months:
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • death
  • erectile dysfunction
  • nausea
  • sweating increased
  • back pain
  • cervicogenic headache
  • chest discomfort
  • cold intolerance
  • cold sweat
6 - 12 months:
  • abnormal weight gain
  • cystitis-like symptom
  • abdominal pain upper
  • fatigue
  • memory impairment
  • nausea
  • acne cystic
  • back pain
  • cleft palate
  • cold intolerance
1 - 2 years:
  • libido decreased
  • low egfr
  • muscle atrophy
  • cleft palate
  • depression
  • drug exposure during pregnancy
  • nausea
  • nausea and vomiting
  • swelling of the ankles - feet - legs
  • abdominal pain upper
2 - 5 years:
  • depression
  • anxiety
  • fatigue
  • pain
  • back pain
  • gambling
  • hepatomegaly
  • penicilliosis
  • swelling of the ankles - feet - legs
  • arthralgia
5 - 10 years:
  • anxiety
  • attention deficit/hyperactivity disorder
  • bipolar disorder
  • crying
  • confusion
  • fatigue
  • ill-defined disorder
  • penicilliosis
  • dizziness
  • dry mouth
10+ years:
  • arthritis
  • elevated liver enzymes
  • endocrine disorder
  • fatigue
  • neurological infection
  • pain
  • pancreatitis chronic
  • stress
  • adverse event
  • blood pressure increased
not specified:
  • fall
  • fatigue
  • depression
  • headache
  • asthenia
  • anxiety
  • drug ineffective
  • weight increased
  • nausea
  • pain

Most common drug interactions by gender *:

female:
  • fall
  • fatigue
  • headache
  • anxiety
  • depression
  • asthenia
  • drug ineffective
  • nausea
  • pain
  • weight increased
male:
  • depression
  • drug ineffective
  • insomnia
  • suicidal ideation
  • aggression
  • dizziness
  • fatigue
  • agitation
  • homicidal ideation
  • muscle atrophy

Most common drug interactions by age *:

2-9:
  • blood creatinine increased
  • blood urea increased
  • hypotension
  • pharyngitis streptococcal
  • pyrexia
  • renal failure acute
  • serum ferritin increased
  • urinary tract infection
  • urosepsis
  • vomiting
10-19:
  • aggression
  • homicidal ideation
  • suicidal ideation
  • self mutilation
  • gallbladder disorder
  • pain
  • poor quality sleep
  • sleep disorder
  • agitation
  • cholecystitis chronic
20-29:
  • attention deficit/hyperactivity disorder
  • depression
  • aggression
  • anxiety
  • bipolar disorder
  • dizziness
  • weight increased
  • constricted affect
  • delusion
  • adverse event
30-39:
  • fatigue
  • dizziness
  • nightmare
  • suicidal ideation
  • headache
  • pyrexia
  • nausea
  • amnesia
  • coordination abnormal
  • disorientation
40-49:
  • drug ineffective
  • asthenia
  • headache
  • fall
  • depression
  • multiple sclerosis
  • fatigue
  • pneumonia
  • blood pressure decreased
  • cachexia
50-59:
  • fall
  • anxiety
  • fatigue
  • back pain
  • chest pain
  • depression
  • headache
  • asthenia
  • contusion
  • nausea
60+:
  • dizziness
  • fatigue
  • feeling abnormal
  • nausea
  • pain in extremity
  • anxiety
  • depression
  • gait disturbance
  • arthralgia
  • asthenia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Adderall xr 30 and Gabapentin?

Can you answer these questions?

More questions for: Adderall xr 30, Gabapentin

You may be interested in these reviews

More reviews for: Adderall xr 30, Gabapentin

On eHealthMe, Adderall xr 30 (amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate) is often used to treat attention deficit hyperactivity disorder. Gabapentin (gabapentin) is often used to treat pain. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.